Brigit Biofarmaka Teknologi Tbk. vs Hatten Bali Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Hatten Bali Tbk. trades at Rp153 (market cap 403.79B, 1.09M 24h volume). The key difference: Hatten Bali Tbk. is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Hatten Bali Tbk. is more actively traded (1.09M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | WINE | |
|---|---|---|
Market Cap | 172.82B | 403.79B |
Volume | 592.2K | 1.09M |
Lot | 5.92K | 10.91K |
Turnover | 147.05M | 174.57M |
Average Price | 248.31 | 160.05 |
Value | 147.05M | 174.57M |
Indicative Equilibrium Price | 254 | 153 |
Indicative Equilibrium Volume | 10 | 295 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Hatten bali, Tbk. (the Company) was established in Bali based on the Notarial Deed No. 90, dated April 15, 2000, drawn up before, I Putu Chandra, S.H Notary at Denpasar. The Company started its commercial operations in 2003.
Read more on WINE →